Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing

• Үндсэн зохиолчид: Elisabeth H. Vollmann (Зохиогч), Lizhi Cao (Зохиогч), Aldo Amatucci (Зохиогч), Taylor Reynolds (Зохиогч), Stefan Hamann (Зохиогч), Isin Dalkilic-Liddle (Зохиогч), Thomas O. Cameron (Зохиогч), Markus Hossbach (Зохиогч), Kevin J. Kauffman (Зохиогч), Faryal F. Mir (Зохиогч), Daniel G. Anderson (Зохиогч), Tatiana Novobrantseva (Зохиогч), Victor Koteliansky (Зохиогч), Tatiana Kisseleva (Зохиогч), David Brenner (Зохиогч), Jeremy Duffield (Зохиогч), Linda C. Burkly (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Elsevier, 2017-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Fibrotic diseases contribute to 45% of deaths in the industrialized world, and therefore a better understanding of the pathophysiological mechanisms underlying tissue fibrosis is sorely needed. We aimed to identify novel modifiers of tissue fibrosis expressed by myofibroblasts and their progenitors...